XI-S+® has been studied in ventral and inguinal overlay procedures in a clinical program conducted outside of the US. The novel cross-linked XI-S+® porcine pericardial biomaterial has been implanted with over 1 year of follow-up and was demonstrated to be well-suited for repairing hernia defects¹.

1. Colorado Therapeutics LLC. Data on file.